CBT
CBT
NYSE · Chemicals

Cabot Corp

$71.05
-1.92 (-2.63%)
As of Nov 7, 1:33 AM ET ·
Financial Highlights (FY 2026)
Revenue
3.63B
Net Income
323.83M
Gross Margin
25.3%
Profit Margin
8.9%
Rev Growth
-4.9%
D/E Ratio
0.73
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 25.3% 25.3% 49.7% 49.7%
Operating Margin 16.7% 15.1% 9.8% 10.6%
Profit Margin 8.9% 8.5% 7.8% 8.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.63B 3.82B 185.80M 154.67M
Gross Profit 919.77M 967.47M 92.35M 76.88M
Operating Income 607.73M 575.32M 18.27M 16.44M
Net Income 323.83M 306.56M 14.53M 13.23M
Gross Margin 25.3% 25.3% 49.7% 49.7%
Operating Margin 16.7% 15.1% 9.8% 10.6%
Profit Margin 8.9% 8.5% 7.8% 8.6%
Rev Growth -4.9% -4.9% +7.5% +12.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 794.25M 794.25M 777.42M 779.25M
Total Equity 1.09B 1.09B 2.58B 2.20B
D/E Ratio 0.73 0.73 0.30 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 758.22M 757.66M 24.94M 19.49M
Free Cash Flow — — 7.01M 6.93M